antineoplastisch middel
Cytotoxic T-lymphocyte-associated protein 4 inhibitor
immunosuppressivum
monoklonaal antilichaam
|
|
|
|
ipilimumab (substantie)
ipilimumab
Ipilimumab
Id
697995005
Status
Primitive
Has disposition
Cytotoxic T-lymphocyte-associated protein 4 inhibitor